The company manufactures and sells a wide range of bathroom accessories and sanitaryware, including faucets, showers, and handles, primarily serving the Indian domestic market.
The company operates in a highly fragmented and competitive industry with no evidence of brand power or cost advantages, as reflected by low net margins and a lack of proprietary technology. The massive jump in reported returns is a function of a low equity base post-conversion rather than durable competitive advantages.
Management recently consolidated several promoter-owned partnership firms into the public entity through slump sales and share issuances. Capital is primarily being used to fund working capital and inventory expansion rather than high-return internal projects.
The investment collapsed as the aggressive revenue growth proved to be a mirage built on related-party slump sales rather than organic demand. The lack of an audit trail and discrepancies between bank filings and internal books eventually culminated in a massive inventory write-down, revealing that the negative cash conversion was a symptom of phantom assets. As the promoter-controlled entity failed to professionalize, the razor-thin margins were entirely consumed by rising working capital costs, leaving minority shareholders with a hollow shell of a business that never generated actual distributable cash.
RichFakir rates Ganga Bath Fittings Ltd's business quality as poor — 26/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Ganga Bath Fittings Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Ganga Bath Fittings Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Ganga Bath Fittings Ltd's fair value is about ₹4 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →